header
Image from OpenLibrary

Retrospective study, oncological and functional outcome following curettage of benign tumors of the calcaneus and the talus / Mohamed Salah Said Mohamed Ahmed ; Supervised Ahmed Amin Galal , Walid Atef Ebeid , Mostafa Salaheldeen Mohamed Salim

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Mohamed Salah Said Mohamed Ahmed , 2021Description: 88 P. : charts , facsimiles ; 25cmOther title:
  • دراسة مرجعية للنتيجة الورمية والوظيفية بعد كحت الأورام الحميدة لعظمة العقب وعظمة الكاحل [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Orthopedic Surgery Summary: Aim: The standard treatment of most of the benign tumors of the talus and the calcaneus traditionally has been intralesional curettage.The purpose of the present study is to evaluate the oncological and functional outcomes of patients with benign tumors of talus and calcaneus treated by curettage.Materials and methods: During the period from July 2001 to April 2021, we conducted a retrospective clinical study to assess the functional and oncological outcome after curettage of benign tumors of talus and calcaneus. The study was done in Cairo university hospitals with a total number of 41 patients. The age ranged from 5 years to 49 years (mean 23.68 years), of 10 females and 31 males.The follow up period ranged from 6 months to 240 months (mean 88.68). Results: The mean functional MSTS score was 28.12. Higher functional MSTS scores were observed in latent lesions compared to active or aggressive lesions (p < 0.05), lesions treated with simple curettage compared to those which treated with extended curettage (p < 0.05). Recurrence rate was 9.8 % (4 patients of 41). In aneurysmal bone cyst it was 20 % (2 patients of 10), in chondromyxoid fibroma it was 50 % (1 patient of 2), and in epithelioid hemangioendothelioma it was 33.3% (1 patient of 3). All of the recurrences occurred within three years after surgery (range from 11 to 31 months). No recurrence was encountered in latent tumors.No recurrence was encountered in patients with chondroblastoma. The complication rate was 12.2% (5 patients of 41).Subtalar arthritis occurred in 2 patients (4.9%), infection in 2 patients (4.9%), and wound gapping in one patient (2.4%)
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.25.M.Sc.2021.Mo.R (Browse shelf(Opens below)) Not for loan 01010110084943000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.25.M.Sc.2021.Mo.R (Browse shelf(Opens below)) 84943.CD Not for loan 01020110084943000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Orthopedic Surgery

Aim: The standard treatment of most of the benign tumors of the talus and the calcaneus traditionally has been intralesional curettage.The purpose of the present study is to evaluate the oncological and functional outcomes of patients with benign tumors of talus and calcaneus treated by curettage.Materials and methods: During the period from July 2001 to April 2021, we conducted a retrospective clinical study to assess the functional and oncological outcome after curettage of benign tumors of talus and calcaneus. The study was done in Cairo university hospitals with a total number of 41 patients. The age ranged from 5 years to 49 years (mean 23.68 years), of 10 females and 31 males.The follow up period ranged from 6 months to 240 months (mean 88.68). Results: The mean functional MSTS score was 28.12. Higher functional MSTS scores were observed in latent lesions compared to active or aggressive lesions (p < 0.05), lesions treated with simple curettage compared to those which treated with extended curettage (p < 0.05). Recurrence rate was 9.8 % (4 patients of 41). In aneurysmal bone cyst it was 20 % (2 patients of 10), in chondromyxoid fibroma it was 50 % (1 patient of 2), and in epithelioid hemangioendothelioma it was 33.3% (1 patient of 3). All of the recurrences occurred within three years after surgery (range from 11 to 31 months). No recurrence was encountered in latent tumors.No recurrence was encountered in patients with chondroblastoma. The complication rate was 12.2% (5 patients of 41).Subtalar arthritis occurred in 2 patients (4.9%), infection in 2 patients (4.9%), and wound gapping in one patient (2.4%)

Issued also as CD

There are no comments on this title.

to post a comment.